Opinion/decision on a Paediatric investigation plan (PIP): N-(6-(((2R,3S)-3,4-dihydroxybutan-2-yl)oxy)-2-((4-fluorobenzyl)thio)pyrimidin-4-yl)-3-methylazetidine-1-sulfonamide (RIST-4721), decision type: , therapeutic area: , PIP number: P/0275/2022

Opinion/decision on a Paediatric investigation plan (PIP): nebivolol (hydrochloride),Amlodipine (besilate), decision type: , therapeutic area: , PIP number: P/0338/2022

Opinion/decision on a Paediatric investigation plan (PIP): nebivolol (hydrochloride), decision type: , therapeutic area: , PIP number: P/0276/2022

Pandemic Influenza Vaccine H5N1 Baxter : EPAR - Public assessment report

Human medicines European public assessment report (EPAR): Mektovi, binimetinib, Melanoma, Date of authorisation: 20/09/2018, Revision: 7, Status: Authorised

Cilostazol : List of nationally authorised medicinal products - PSUSA/00010209/202301

United States

Cimicifuga racemosa (L.) nutt., rhizoma : List of nationally authorised medicinal products - PSUSA/00000755/202301

Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Heart Failure, Date of authorisation: 19/11/2015, Revision: 18, Status: Authorised

20 years of EU / US collaboration on medicines regulation